SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy
Vasogen-- VAS on TSE
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
377 19 0 VSGN
Emcee:  caly Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
302I think of it as a medical process. vasogen.comcaly-7/27/2005
301I thought it is a medical device, not a drug. Am I wrong?Michael Young-7/27/2005
300Of course what Vasogen has in Phase III testing is not a drug, it's a proceStephen O-7/26/2005
299<i>If a new process produces dramatic results against inflammation, then tPluvia-7/26/2005
298The FDA is in a state of opprobrium anyway. If a new process produces dramatic rStephen O-7/26/2005
297<i>If what they have works then that is the dose. If it is really succesfuPluvia-7/26/2005
296hey hey, glad to see you're back - how's tricks?Pluvia-7/26/2005
295a ghost from the past returns. SCANSHIFT, after 5 years and 8 months, has his poscanshift-7/26/2005
294If what they have works then that is the dose. If it is really succesful, the meStephen O-7/26/2005
293Vasogen's problem is significantly more severe. Vasogen can't identify Pluvia-7/26/2005
292As to the issue of not knowing what is the drug, there is a similar situation witnsaf-7/26/2005
291Vasogen is an interesting company, but they have some issues with their technoloPluvia-7/24/2005
290Not buying in so slowly now... finance.yahoo.comcaly-7/12/2005
289It would seem people have slowly been buying in in anticipation of good news. Mcaly-6/21/2005
288calypso: Well it would appear that the time is close for make or break. AnnouncTom Drolet-6/21/2005
287Forbes article on Celacade... forbes.com Blood Works Mary Ellen Egan, 06.06.05caly-5/25/2005
286Date Research Firm Action From To 14-Apr-05 Adams Harkness Initiated Strong Bcaly-4/14/2005
285Vasogen Receives Approval to Advance New Drug for Neuro-inflammatory Disease intcaly-1/24/2005
284The "CNBC Effect" is in full swing... finance.yahoo.comcaly-1/10/2005
283According to a Yahoo poster who called the company to confirm, the CEO of Vasogecaly-1/7/2005
282Based on the competitive products listed in that biotech report, here's a licaly-1/5/2005
281I was going to copy part of the article from the NEJM here, but better not. Vacaly-1/5/2005
280Forbes has the story too, though they don't mention Vasogen. forbes.comStephen O-1/5/2005
279See bold for competing products... Reducing inflammation as an emerging target caly-1/5/2005
278There was a lengthy story on the ABC National News tonight about the recent articaly-1/5/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News